BioSpace News Archive

Humanetics announced today that ATD-LabTech GmbH, which offers state-of-the art ATD certification equipment and comprehensive ATD lab management software, will be joining them.

InfuSystem Holdings, Inc., a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced it will issue second quarter 2022 financial results on Thursday, August 4, 2022, before the market opens.

GreenLight Biosciences has announced a collaboration with the National Institutes of Health to develop COVID-19 vaccines that are more broadly protective against new variants and with longer-lasting effects.

Trevena, Inc. announced the closing of its previously announced registered direct offering with a single healthcare-focused institutional investor for the purchase and sale of 1,800 shares of Series A convertible preferred stock and 200 shares of Series B convertible preferred stock and warrants exercisable to purchase up to an aggregate of 8,000,000 shares of common stock.

BIOASIS TECHNOLOGIES INC., a biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across the blood-brain barrier announced that it has filed its unaudited quarterly financial statements and management’s discussion and analysis for the period ended May 31, 2022.